(Q37926332)

25 August 2017

1 reference

title

Ciprofloxacin. Best use of this new broad-spectrum antibiotic (English)

1 reference

25 August 2017

Fass RJ

1

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 June 1990

1 reference

25 August 2017

published in

Postgraduate Medicine

1 reference

25 August 2017

volume

87

1 reference

25 August 2017

issue

8

1 reference

25 August 2017

page(s)

117-22, 124, 127-31

1 reference

Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704677

Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704677

The in vitro and in vivo activity of ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704677

Norfloxacin: a new targeted fluoroquinolone antimicrobial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704677

In vitro susceptibilities of four species of coagulase-negative staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704677

Long-term oral ciprofloxacin: experience in the treatment of incurable infective endocarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704677

Pharmacokinetics of ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704677

Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704677

Enoxacin raises plasma theophylline concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704677

Clinical experience with ciprofloxacin in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704677

Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704677

Ciprofloxacin in the treatment of urinary tract infection due to enterobacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704677

Prospective study of lower respiratory tract infections in an extended-care nursing home program: potential role of oral ciprofloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704677

Treatment of chronic salmonella carriers with ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704677

10.1080/00325481.1990.11704677

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference